Patent application number | Description | Published |
20120009562 | High-Risk Human Papillomavirus Detection - This invention provides compositions and methods for detecting HPV in a sample. This invention also provides related kits, systems, and computers. | 01-12-2012 |
20120009563 | High-Risk Human Papillomavirus Detection - This invention provides compositions and methods for detecting HPV in a sample. This invention also provides related kits, systems, and computers. | 01-12-2012 |
20120009564 | High-Risk Human Papillomavirus Detection - This invention provides compositions and methods for detecting HPV in a sample. This invention also provides related kits, systems, and computers. | 01-12-2012 |
20120190008 | GENERIC PCR - The present invention provides a method for the amplification of at least a first and a second target nucleic acid that may be present in a fluid sample. The invention further provides a kit and an analytical system for carrying out said amplification. | 07-26-2012 |
20120196291 | Control Nucleic Acids For Multiple Parameters - The present invention concerns the amplification of at least a first and a second target nucleic acid that may be present in at least one fluid sample using an internal control nucleic acid for qualitative and/or quantitative purposes. | 08-02-2012 |
20130266938 | Format of Probes to Detect Nucleic Acid Differences - The invention provides, inter alia, novel probes, methods, reaction mixtures, and kits for detecting the presence or absence of a target nucleic acid sequence. | 10-10-2013 |
20140120547 | ALKYL AMINES IMPROVE DETECTION OF COMPONENTS OF FORMALDEHYDE-FIXED BIOLOGICAL SAMPLES - Alkyl amines act to release formaldehyde cross-linking that occurs in biological samples. Thus, contacting alkyl amines to formaldehyde fixed samples is a useful way to render biological components of the samples, including nucleic acids or proteins, more accessible to detection and characterization. | 05-01-2014 |
20140242592 | Allele-Specific Amplification - The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, but having a 3′-terminal nucleotide complementary to only one variant of the target sequence and having at least one nucleotide with a base covalently modified at the exocyclic amino group, wherein the allele-specific oligonucleotide is extended by a nucleotide-incorporating biocatalyst predominantly when hybridized to the variant of the target sequence for which it has said complementary 3′-terminal nucleotide. | 08-28-2014 |